Skip to main content
Consumer site
French version coming soon
KenvuePro Logo

Order samples

References

1. Data on file, Kenvue Canada Inc.. Based on overall mean percentage of healthy sites per subject after 6 months. Post hoc analysis of Sharma et al clinical study. Sharma N, Charles CH, Lynch M, et al. Adjunctive benefit of an essential oil-containing mouthrinse in reducing plaque and gingivitis in patients who brush and floss regularly: a six month study. Am J Dent Assoc. 2004;135(4):496-504.

2. Sharma N, Charles CH, Lynch MC, et al. Adjunctive benefit of an essential oil-containing mouthrinse in reducing plaque and gingivitis in patients who brush and floss regularly: a six-month study. J Am Dent Assoc. 2004;135:496-504.

3. CDA Seal Program Recognized Products: http://www.cda-adc.ca/en/oral_health/seal/products.

4. DePaola LG, Overholser CD, Meiller TF, Minah GE, Niehaus C. Chemotherapeutic inhibition of supragingival dental plaque and gingivitis development. J Clin Periodontol. 1989;16:311-315.

5. Health Canada Product License for LISTERINE SMART RINSE® for KIDS

6. Morris A, Santos S, Sinatra K, et al. Plaque removal of revolutionary monofilament floss with Flexible MICRO-GROOVES®. J Dent Res 2009;88(Spec Issue A): Abstract 1574.

7. Asadoorian J. Canadian Dental Hygienists Association Position Statement on Oral Rinsing. CJDH 2006;40(4):1-13

8. Ipsos Mouthwash Omnibus Study. December 20, 2001.

9. Health Canada. Canadian Health Measures Survey 2007-2009, Table 15, Page 83.

10. DePaola LG, Spolarich AE. Safety and efficacy of antimicrobial mouthrinses in clinical practice. J Dent Hygiene. 2007;81(special suppl):13-25.

11. Fine DH, Furgang D, Lieb R, Korik I, Vincent JW, Barnett ML. Effects of sublethal exposure to an antiseptic mouthrinse representative plaque bacteria. J Clin Periodontol. 1996;23(5):444-451.

12. Ricci-Nittel D, Fourre T. In vivo evaluation of antimicrobial activity of an essential-oil mouthrinse. Presented at: General Session of the International Association for Dental Research; March 16-19, 2011; San Diego, CA. Oral Session.

13. Pan PC, Harper S, Ricci-Nittel D, Lux R, Shi W. In-vitro evidence for efficacy of antimicrobial mouthrinses. J Dent. 2010;38(suppl 1):S16-20.

14. Fine DH, Letizia J, Mandel ID. The effect of rinsing with Listerine antiseptic on the properties of developing dental plaque. J Clin Periodontol. 1985;12:660-666.

15. Ross NM, Charles CH, Dills SS. Long-term effects of Listerine antiseptic on dental plaque and gingivitis. J Clin Dent. 1989;1(4):92-95.

16. Drake D, Villhauer AL. An in vitro comparative study determining bactericidal activity of stabilized chlorine dioxide and other oral rinses. J Clin Dent. 2011;22(1):1-5.

17. Andreana S, Nittel-Ricci D, Wu MM, Harper DS, Baxter KA. 2205 In vitro antimicrobial activity of vanilla mint Listerine® antiseptic mouthrinse. Presented at: IADR/AADR/CADR 85th General Session and Exhibition. March 2007.

18. Pan PH, Finnegan MB, Sturdivant L, Barnett ML. Comparative antimicrobial activity of an essential oil and an amine fluoride/stannous fluoride mouthrinse in vitro. J Clin Periodontol. 1999;26(7):474-476.

19. Fine DH, Furgang D, Barnett ML, et al. Effect of an essential oil-containing antiseptic mouthrinse on plaque and salivary Streptococcus mutans levels. J Clin Periodontol. 2000;27(3):157-161.

20. Fine DH, Letizia J, Mandel ID. The effect of rinsing with Listerine antiseptic on the properties of developing dental plaque. J Clin Periodontol. 1985;12:660-666.

21. DePaola LG. Safety and efficacy of antimicrobial mouthrinses in clinical practice. J Dent Hygiene. 2007 (special suppl);13:13-25.

22. Meiller TF, Kelley JI, et al. In vitro studies of the efficacy of antimicrobials against fungi. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2001;91:663-670.

23. Fischman SL, Aquirre A, Charles CH. Use of essential oil-containing mouthrinses by xerostomic individuals: determination of potential for oral mucosal irritation. Am J Dent. 2004;17:23-26.

24. Kerr AR, Katz RW, Ship JA. A comparison of the effects of 2 commercially available nonprescription mouthrinses on salivary flow rates and xerostomia. Quintessence Int. 2007;38(705):41-48.

25. Kerr AF, Kalliontzi PM, Corby PM, Thai K, Charles C, McGuire J. Comparsion of two mouthrinses on salivary flow and perceived dryness. Abstract. Presented at: IADR General Session. San Diego, CA. March 17, 2011. https://iadr.confex.com/iadr/2011sandiego/webprogram/Paper145075.html

26. Food and Drug Administration. Oral health care drug products for over-the-counter human use; antigingivitis/antiplaque drug products; establishment of a monograph; proposed rules. Part III. Federal Register. 2003;68(103):32232-32287.

27. Cole P, Rodu B, Mathisen A. Alcohol-containing mouthwash and oropharyngeal cancer: a review of the epidemiology. J Am Dent Assoc. 2003;134:1079-1087.

28. La Vecchia C. Mouthwash and oral cancer risk: an update. Oral Oncol. 2009;45(3):198-200.

29. Boyle P, Gandini S, Boffetta P, Negri E, La Vecchia C. Mouthwash use and oral cancer risk: quantitative meta-analysis of epidemiologic studies. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2011;.112(6):}e130.

30. Marsh PD, Martin MV, Lewis MOA, Williams D. Dental Plaque. Oral Microbiology E-Book, 5th Edition. Churchill Livingstone. 2009. 80-89.

31. Bakdash B. Current patterns of oral hygiene product use and practice. Peridontal 2000. 1995;8:11-14.

32. Cancro LP, Fischman SL. The expected effect on oral hygiene of dental plaque control through mechanical removal. Periodontal 2000. 1995;8:60-74.

33. Brush Teeth. Mouth Healthy Web site. http://www.mouthhealthy.org/en/az-topics/b/brushing-your-teeth. Accessed July 17, 2015.

34. Bader HI. Floss or die: implications for dental professionals. Dent Today. 1998;17:76-82.

35. Health Canada, Canadian Health Measures Survey 2007-2009. “Prevalence and severity of coronal caries – dentate adults”.

36. Health Canada, Canadian Health Measures Survey 2007-2009. “Percent of participants by highest score for gingivitis – dentate adults”.

37. Health Canada, Canadian Health Measures Survey 2007-2009. “Prevalence and severity of dental caries in primary teeth – ages 6-12”.

38. Kerr WJS, Kelly J, Geddes DAM. The areas of various surfaces in the human mouth from nine years to adulthood. J Dent Res. 1991;70:1528-1530.

39. Charles CH, Mostler KM, Bartels LL, Mankodi SM. Comparative antiplaque and antigingivitis effectiveness of a chlorhexidine and an essential oil mouthrinse: 6-month clinical trial. J Clin Periodontol. 2004;31(10):878-884.

40. Lisante TA, Charles C, Qaqish J, Sharma N, Junker L. Efficacy of brush, floss, rinse regiments vs mechanical oral hygiene. Presented at: 86th General Session of the International Association for Dental Research; March 16-19, 2011; San Diego CA.

41. Overholser CD, Meiller TF, DePaola LG, Minah GE, Niehaus C. Comparative effects of 2 chemotherapeutic mouthrinses on the development of supragingival dental plaque and gingivitis. J Clin Periodontol. 1990;17:575-579.

42. Data on file, Kenvue Canada Inc..

43. Lamster IB, Alfano MC, Seiger MC, Gordon JM. The effect of LISTERINE® Antiseptic on reduction of existing plaque and gingivitis. Clin Prev Dent. 1983;5:12-16.

44. Cortelli SC, Cortelli JR, Shang H, Costa R, Charles CA. Gingival health benefits of essential-oil and cetylpyridinium chloride mouthrinses: A 6-month randomized clinical study. American Journal of Dentistry. 2014;Vol.27, No.3.

45. Pan P, Barnett ML, Coelho J et al. Determination of the in situ bactericidal activity of an essential oil mouthrinse using a vital stain method. Clin Periodontal 2000;27(4):256-261

46. Charles CA, Vair LH, Queiroz D, et al. Comparing consumer acceptance and perceived benefits of two floss technologies. J Dent Hyg. 2009;83(4):222.